Publication|Videos|July 18, 2024
PurpleLab Accelerates Clinical Trial Lifecycle with Real-World-Data
Author(s)PurpleLab
Jason Gagner (Vice President of Product for Life Science, PurpleLab) talks about clinical trial variables and how PurpleLab is working to maintain patient retention and accelerate site feasibility.
Advertisement
Approximately 80% of clinical trials will face delays at some point in the trial process. Jason Gagner talked with ACT about how PurpleLab uses real-world data to better inform trials and improve their success rates.
Learn More About:
- Utilizing real-world data (RWD) to assist clinical trials achieve key milestones
- Employing a criteria specific geographic analysis of patient populations to expedite site feasibility assessments
- Understanding the impact of diversity, equity, and inclusion (DEI) in clinical trials on meeting trial objectives and timelines
- Integrating social determinants of health (SDOH) data to minimize patient dropout rates
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Accelerate Inclusive Enrollment and Delivery with Lightship
February 19th 2025
- Harmonizing Data in Clinical Research
October 21st 2024
- Parexel’s FSP: Evolving With Your Needs Now and in the Future
October 3rd 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Latest NIMBLE Study Results Highlight Progress in gMG Research
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
5